Loading...
Nordic Life Science 1
COMBINOSTICS IS AIMING TO EXPAND ITS PLATFORM FOR
EARLY DETECTION OF NEURODEGENERATION INTO NEW MARKETS AND SEES AN INCREASING DEMAND FOR TECHNOLOGIES SUCH AS THEIRS. T E X T by M AL I N O TM AN I PHOTO JUSSI MATTILA